{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:01:35Z","timestamp":1791298895459,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1002\/jps.23897","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T19:16:41Z","timestamp":1392232601000},"page":"1288-1297","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacokinetic\/Pharmacodynamic Modeling for Concentration-Dependent Bactericidal Activity of a Bicyclolide, Modithromycin"],"prefix":"10.1016","volume":"103","author":[{"given":"Takayuki","family":"Katsube","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Wajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.23897_bb0001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.pharmtox.40.1.67","article-title":"Pharmacokinetic\/pharmacodynamic modeling in drug development","volume":"40","author":"Sheiner","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1002\/jps.23897_bb0002","first-page":"566","article-title":"Current concepts in pharmacokinetics and their implications for clinical medicine","volume":"113","author":"M\u00fcller","year":"2001","journal-title":"Wien Klin Wochenschr"},{"key":"10.1002\/jps.23897_bb0003","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1208\/aapsj070355","article-title":"Pharmacokinetics\/pharmacodynamics and the stages of drug development: Role of modeling and simulation","volume":"7","author":"Chien","year":"2005","journal-title":"AAPS J"},{"key":"10.1002\/jps.23897_bb0004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/clinids\/3.1.19","article-title":"Kinetics of antimicrobial action","volume":"3","author":"Mattie","year":"1981","journal-title":"Rev Infect Dis"},{"key":"10.1002\/jps.23897_bb0005","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/jps.2600731025","article-title":"Kinetic analysis and characterization of the bacterial regrowth after treatment of Escherichia coli with \u00df-lactam antibiotics","volume":"73","author":"Hamano","year":"1984","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23897_bb0006","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/jps.2600731024","article-title":"Microbial kinetics of \u00df-lactam antibiotics against Escherichia coli","volume":"73","author":"Tsuji","year":"1984","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23897_bb0007","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01062551","article-title":"Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa","volume":"16","author":"Zhi","year":"1988","journal-title":"J Pharmacokin Biopharm"},{"key":"10.1002\/jps.23897_bb0008","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/jac\/27.3.319","article-title":"Biphasic kinetics of bacterial killing by quinolones","volume":"27","author":"Carret","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.23897_bb0009","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jps.2600830711","article-title":"Pharmacodynamic modeling of bacterial kinetics: \u00df-Lactam antibiotics against Escherichia coli","volume":"83","author":"Li","year":"1994","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23897_bb0010","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/js9801337","article-title":"Application of logistic growth model to pharmacodynamic analysis of in vitro bactericidal kinetics","volume":"87","author":"Yano","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23897_bb0011","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10928-007-9069-x","article-title":"Mechanism-based pharmacokinetic\u2013pharmacodynamic modeling of antimicrobial drug effects","volume":"34","author":"Czock","year":"2007","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1002\/jps.23897_bb0012","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.00604-06","article-title":"Semimechanistic pharmacokinetic\/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments","volume":"51","author":"Nielsen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.23897_bb0013","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/jac\/dkm370","article-title":"Mathematical modelling response of Pseudomonas aeruginosa to meropenem","volume":"60","author":"Tam","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.23897_bb0014","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/AAC.00489-08","article-title":"Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa","volume":"53","author":"Bulitta","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.23897_bb0015","series-title":"The chemical basis of growth and senescence","author":"Robertson","year":"1923"},{"key":"10.1002\/jps.23897_bb0016","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01062346","article-title":"A pharmacodynamic model for cell-cycle specific chemotherapeutic agents","volume":"1","author":"Jusko","year":"1973","journal-title":"J Pharmacokin Biopharm"},{"key":"10.1002\/jps.23897_bb0017","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1002\/jps.21265","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling and simulation for bactericidal effect in an in vitro dynamic model","volume":"97","author":"Katsube","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23897_bb0018","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/jps.21062","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling and simulation for in vivo bactericidal effect in murine infection model","volume":"97","author":"Katsube","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23897_bb0019","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/jps.21997","article-title":"Pharmacokinetic\/pharmacodynamic modeling and simulation to determine effective dosage regimens for doripenem","volume":"99","author":"Katsube","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23897_bb0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1517\/14656566.9.2.267","article-title":"Ketolides: Pharmacological profile and rational positioning in the treatment of respiratory tract infections","volume":"9","author":"Van Bambeke","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1002\/jps.23897_bb0021","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/jac\/dkq147","article-title":"In vitro antibacterial activities of S-013420, a novel bicyclolide, against respiratory tract pathogens","volume":"65","author":"Homma","year":"2010","journal-title":"J. Antimicrob Chemother"},{"key":"10.1002\/jps.23897_bb0022","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1128\/AAC.00214-10","article-title":"In vitro pharmacokinetic and pharmacodynamic evaluation of S-013420 against Haemophilus influenzae and Streptococcus pneumoniae","volume":"54","author":"Homma","year":"2010","journal-title":"Antimicrob Agent Chemother"},{"key":"10.1002\/jps.23897_bb0023","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1128\/AAC.00022-09","article-title":"Pharmacokinetics of EDP-420 after multiple oral doses in healthy adult volunteers and in a bioequivalence study","volume":"53","author":"Jiang","year":"2009","journal-title":"Antimicrob Agent Chemother"},{"key":"10.1002\/jps.23897_bb0024","article-title":"The pharmacokinetics (PK), safety and tolerability of S-013420, a novel bicyclolide in healthy Japanese male subjects","author":"Shimada","year":"2007","journal-title":"47th Interscience Conference on Antimicrobial Agents Chemotherapy. Abstract #A-799."},{"key":"10.1002\/jps.23897_bb0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF01061691","article-title":"Comparison of four basic models of indirect pharmacodynamic responses","volume":"21","author":"Dayneka","year":"1993","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1002\/jps.23897_bb0026","series-title":"NONMEM users guide","author":"Beal","year":"1989"},{"key":"10.1002\/jps.23897_bb0027","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","article-title":"Ways to fit a PK model with some data below the quantification limit","volume":"28","author":"Beal","year":"2001","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1002\/jps.23897_bb0028","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1208\/s12248-009-9112-5","article-title":"Handling data below the limit of quantification in mixed effect models","volume":"11","author":"Bergstrand","year":"2009","journal-title":"AAPS J"},{"key":"10.1002\/jps.23897_bb0029","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00003495-200161060-00001","article-title":"Aminoglycoside adaptive resistance: Importance for effective dosage regimens","volume":"61","author":"Barclay","year":"2001","journal-title":"Drugs"},{"key":"10.1002\/jps.23897_bb0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/infdis\/162.2.414","article-title":"Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation","volume":"162","author":"Daikos","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1002\/jps.23897_bb0031","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/AAC.00567-09","article-title":"Intrapulmonary pharmacokinetics of S-013420, a novel bicyclolide antibacterial, in healthy Japanese subjects","volume":"54","author":"Furuie","year":"2010","journal-title":"Antimicrob Agent Chemother"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915306432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915306432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T14:20:54Z","timestamp":1538835654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915306432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0022354915306432"],"URL":"https:\/\/doi.org\/10.1002\/jps.23897","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}